These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 38077888)

  • 1. Retracted: Identification and Validation of a Novel Prognostic Gene Model for Colorectal Cancer.
    Methods In Medicine CAM
    Comput Math Methods Med; 2023; 2023():9801316. PubMed ID: 38077888
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Retracted: Identification and Validation of Invasion-Related Molecular Subtypes and Prognostic Features for Cervical Cancer.
    Methods In Medicine CAM
    Comput Math Methods Med; 2023; 2023():9853237. PubMed ID: 37475921
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Retracted: Identification of a Novel Risk Model: A Five-Gene Prognostic Signature for Pancreatic Cancer.
    And Alternative Medicine EC
    Evid Based Complement Alternat Med; 2023; 2023():9831949. PubMed ID: 37388014
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Retracted: Identification and Validation of an Inflammatory Response-Related Polygenic Risk Score as a Prognostic Marker in Hepatocellular Carcinoma.
    Markers D
    Dis Markers; 2023; 2023():9809678. PubMed ID: 37538093
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Retracted: Identification of a Ferroptosis-Related Prognostic Signature in Sepsis via Bioinformatics Analyses and Experiment Validation.
    International BR
    Biomed Res Int; 2024; 2024():9785480. PubMed ID: 38550060
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Retracted: Development and Validation of a Novel Mitophagy-Related Gene Prognostic Signature for Hepatocellular Carcinoma Based on Immunoscore Classification of Tumor.
    Oncology JO
    J Oncol; 2023; 2023():9803262. PubMed ID: 37869587
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Retracted: Identification of a 5-Nutrient Stress-Sensitive Gene Signature to Predict Survival for Colorectal Cancer.
    International BR
    Biomed Res Int; 2024; 2024():9823079. PubMed ID: 38550151
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Retracted: The Number of Intraoperative Intestinal Venous Circulating Tumor Cells Is a Prognostic Factor for Colorectal Cancer Patients.
    And Alternative Medicine EC
    Evid Based Complement Alternat Med; 2023; 2023():9864685. PubMed ID: 38093869
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Retracted: Identification of Key MicroRNAs and Genes between Colorectal Adenoma and Colorectal Cancer via Deep Learning on GEO Databases and Bioinformatics.
    Imaging CMM
    Contrast Media Mol Imaging; 2023; 2023():9868906. PubMed ID: 37564892
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Retracted: Identification of Novel CircRNA-miRNA-mRNA Regulatory Network and Its Prognostic Prediction in Breast Cancer.
    And Alternative Medicine EC
    Evid Based Complement Alternat Med; 2023; 2023():9870845. PubMed ID: 37387864
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Retracted: Identification of Ferroptosis-Related Long Noncoding RNA and Construction of a Novel Prognostic Signature for Gastric Cancer.
    Markers D
    Dis Markers; 2023; 2023():9810178. PubMed ID: 37387742
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Retracted: Clinical Characteristics of Metastatic Colorectal Cancer Combined with Gastrointestinal Perforation and Prognostic Value of Circulating Tumor DNA.
    International EM
    Emerg Med Int; 2024; 2024():9831920. PubMed ID: 38298956
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Retracted: Analysis of Efficacy, Safety, and Prognostic Factors of mFOLFOX6 Regimen Combined with Cetuximab and Simvastatin in the Treatment of K-RAS Mutant Colorectal Cancer.
    And Alternative Medicine EC
    Evid Based Complement Alternat Med; 2023; 2023():9817296. PubMed ID: 37388090
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Retracted: Identification of Immune-Related Prognostic Markers in Gastric Cancer.
    Healthcare Engineering JO
    J Healthc Eng; 2023; 2023():9862096. PubMed ID: 37772021
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Retracted: The Function and Prognostic Value of RNA-Binding Proteins in Colorectal Adenocarcinoma Were Analyzed Based on Bioinformatics of Smart Medical Big Data.
    Healthcare Engineering JO
    J Healthc Eng; 2023; 2023():9896539. PubMed ID: 37266289
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Retracted: Identification of the HMMR Gene as a Diagnostic and Prognostic Biomarker in Hepatocellular Carcinoma Based on Integrated Bioinformatics Analysis.
    And Alternative Medicine EC
    Evid Based Complement Alternat Med; 2023; 2023():9819147. PubMed ID: 37808149
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Retracted: Study on the Relationship between MMP-2, MMP-9 Gene Polymorphisms, and the Risk of Colorectal Cancer.
    And Alternative Medicine EC
    Evid Based Complement Alternat Med; 2023; 2023():9813768. PubMed ID: 37501848
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Retracted: Identification and Validation of Immune Markers in Coronary Heart Disease.
    Methods In Medicine CAM
    Comput Math Methods Med; 2023; 2023():9763590. PubMed ID: 38077869
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Retracted: Analysis of KRAS Mutation Status Prediction Model for Colorectal Cancer Based on Medical Imaging.
    Methods In Medicine CAM
    Comput Math Methods Med; 2023; 2023():9815960. PubMed ID: 37416188
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Retracted: Identification and Validation of Key Genes in Hepatocellular Carcinoma by Bioinformatics Analysis.
    International BR
    Biomed Res Int; 2024; 2024():9784513. PubMed ID: 38230025
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.